Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Novo Nordisk Farma Oy
Woman and Man Max 99 years
Novo Nordisk Farma Oy
Update Il y a 5 ans
A one-year, multi-national, open-labelled, parallel-group, 2:1 randomised treat-to-target trial comparing efficacy and safety of insulin detemir with insulin glargine using a basal-bolus regimen with insulin aspart as mealtime insulin in subjects with type 1 diabetes
To compare the glycaemic control of insulin detemir with that of insulin glargine as measured by HbA1c in subjects with type 1 diabetes on a basal-bolus regimen with insulin aspart as bolus insulin af...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Novo Nordisk Farma Oy
Update Il y a 5 ans
NordiNet International Outcome Study (NordiNet IOS)
To collect the post-marketing data on effectiviness and safety of real-life treatment with Norditropin.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Novo Nordisk Farma Oy
Update Il y a 5 ans
A one-year, multi-national, open-labelled, parallel-group, 2:1 randomised treat-to-target trial comparing efficacy and safety of insulin detemir with insulin glargine using a basal-bolus regimen with insulin aspart as mealtime insulin in subjects with type 2 diabetes
To compare the glycaemic control of insulin detemir with that of insulin glargine as measured by HbA1c in subjects with type 2 diabetes on a basal-bolus regimen with insulin aspart as bolus insulin af...
Country
None
organs
None
Specialty
None
Closed trial
More information